Adverse Reactions to Immunotherapy Can Appear After a Year
Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […]
» Read moreHome »
In a new randomized trial that investigated the question of whether thrombolysis can be omitted for stroke patients undergoing endovascular […]
Is There a Need for tPA Before Thrombectomy in Stroke?
